Publications by authors named "Martin Hoehl"
Article Synopsis
- SARS-CoV-2, which emerged in late 2019, has caused a global pandemic, with 34 vaccines approved and about 67% of the world vaccinated, yet new infections and variants still pose challenges.
- Researchers evaluated a new measles virus-vectored vaccine (V591) designed to target the SARS-CoV-2 spike protein in an African green monkey model, demonstrating strong immune responses pre-challenge.
- V591-vaccinated monkeys showed reduced viral loads and earlier cessation of virus shedding after exposure to SARS-CoV-2, leading to a lower disease burden in their lungs compared to those given a control vaccine.
Aim: It can be challenging to distinguish COVID-19 in children from other common infections. We set out to determine the rate at which children consulting a primary care paediatrician with an acute infection are infected with SARS-CoV-2 and to compare distinct findings.
Method: In seven out-patient clinics, children aged 0-13 years with any new respiratory or gastrointestinal symptoms and presumed infection were invited to be tested for SARS-CoV-2.